Technology Transfer and Innovation

According to the National Board for the Assessment of Higher Education (CONAES), technology transfer and business development “makes research findings, knowledge and skills usable or commercializable”. Its aims to increase the value of research findings, to guarantee their impact from a social and economic perspective.

As indicated in the French Research Code (Article L111-1), the commercialization of research findings is part and parcel of the researcher’s remit – Research Code L111-1.

Technology transfer concerns the commercialization of public research findings in industry.

Technology transfer and business development is a virtuous circle leading from invention to innovation, a laboratory process to the market via a license or startup, and requires contacts with the social and economic world.

• Practical guide to technology transfer, business development and innovation
• Innovate with public research MOOC

Researchers are the focus of Université Paris Cité’s business development policy through technology transfer. Within this ecosystem, we have introduced with partners such as the CNRS and CNRS Innovation, the INSERM and INSERM Transfert, the APHP, the SATT Erganeo and incubators, among which Université Paris Cité Paris Biotech Santé, we are able to provide continuity of support for researchers up to the point of technology transfer.

Providing support is:

• Signposting the path to technology transfer and business development
• Building bridges with the social and economic world (teamwork, services, CIFRE, etc.)
• Providing expertise (intellectual property, PACTE Law, creation of startups, etc.)
• Financing systems to mature projects
• Building the skills of the project initiators
• Publicizing these projects and their teams

And especially, listening to and advising researchers.

Damien Marchal, Vice President, in charge of the technology transfer of research and industrial partnerships, answers the key questions in this column: Partnership-based research and technology transfer: a major challenge for Université Paris Cité. (the content is in french)

With the goal of accelerating the way research commercialization is structured, through partnerships and technology transfer within the establishment, Université Paris Cité hosted Bpifrance on 22 October 2020 during an all-digital event, the DeepTech Tour. You can see a replay if you follow this link.

From the day it was founded, Université Paris Cité has supported the development of innovative projects with an entrepreneurial aspect, through the IdEx Prematurity AMI. This AMI (Appel à Manifestation d’Intérêt) aims to finance and showcase any innovative project emerging from the laboratories within the scope of the University Paris Cité. The goal is to develop the project’s proof of concept with a view to its future maturity and to increase the project initiators’ awareness of the challenges of the social an economic world.

In 2020, Université Paris Cité selected 20 innovative projects. The winning projects were picked out by a selection committee made up of representants of its ecosystem. The project leaders benefit from financial leverage and aid, enabling them to achieve their proof of concept. This arrangement helps finance projects up to €50 K (HR costs, services, consumables) for 12 months maximum.

More information to apply for the IdEx prematurity AMI. (Content is in French)